5 Best Sliver Stocks To Buy Right Now


By Hal M. Bundrick

NEW YORK (MainStreet) There have been 193 initial public offerings priced in the U.S. this year, an increase of nearly 60% from last year, and a trend on-track to be the most deals seen since the Dot Com bubble of 2000, according to Renaissance Capital.

Why the sudden interest? The CFA Institute, an association of investment professionals, asked members to pinpoint the possible reasons for the surge in IPOs.

“Despite what some might characterize as a building froth, only 28% of the 608 respondents to [our] global poll consider this upswing in IPO activity troubling and indicative of a bubble,” writes David Larrabee, director of member and corporate products at the CFA Institute, in a report on the poll. “A plurality of respondents, 38%, attribute the strength to healthy capital markets and investor bullishness, and 26% simply see risk taking on the rise but, importantly, no cause for alarm.” Just 8% of respondents to the poll attributed the increase in IPOs to relaxed capital raising rules. Particularly notable is the reversal of fortune for historically poor IPO performance. Renaissance reports the average return for IPOs improved on a sequential basis to 27% in the third quarter, well above the S&P’s 5% and the Russell’s 6% quarterly gains. “Performance was driven primarily by a higher average first-day pop, which spiked to 19%, the highest level seen since the 2Q 03’s 24%,” a Renaissance analysis says. Excluding NRG Yield, a rare utilities IPO that garnered strong favor, the research firm reports that the consumer, technology and health care sectors continued to generate the highest returns. Sprouts Farmers Market, a natural and organic grocery chain, has gained 147% since its rollout in late July, putting the consumer sector in the IPO headlines. Three of the top five tech IPOs were on-demand software firms, including cyber security software provider FireEye, which ended the quarter 108% above its offering price. Health care IPO returns were driven by cancer diagnostics company Foundation Medicine, with a 120% total return, as well as a handful of biotech firms. IPOs tied to the housing and construction sectors produced the lowest returns for the third quarter of this year. –Written by Hal M. Bundrick for MainStreet

5 Best Sliver Stocks To Buy Right Now: Alnylam Pharmaceuticals Inc.(ALNY)


Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). Its core product programs under clinical or pre-clinical development include ALN-TTR, a Phase I clinical trial program for the treatment of transthyretin-mediated amyloidosis; ALN-APC, a Phase I clinical trial program for the treatment of hemophilia; ALN-PCS for the treatment of severe hypercholesterolemia; ALN-HPN, a pre-clinical development for the treatment of refractory anemia; and ALN-TMP, a pre-clinical development for the treatment of hemoglobinopathies, including beta-thalassemia and sickle cell anemia. The company?s partner-based programs comprise ALN-RSV01, a Phase II clinical trial program for the treatment of respiratory syncytial virus infection; ALN-VSP, a Phase I clinical trial completed program for the treatment of liver cancers; and ALN-HTT, a pre-clinical development for the treatment of H untington?s disease. It has strategic alliances with Novartis Pharma AG; F. Hoffmann-La Roche Ltd; Takeda Pharmaceutical Company Limited; Isis Pharmaceuticals, Inc.; Medtronic Inc.; Kyowa Hakko Kirin Co., Ltd.; and Cubist Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.


Advisors’ Opinion:

  • [By Jake L’Ecuyer]

    Equities Trading UP
    Shares of Alnylam Pharmaceuticals (NASDAQ: ALNY) got a boost, shooting up early in the day, but settling on a gain of 40.40 percent to $92.96 after the company reported that it has acquired investigational RNAi Therapeutic assets from Merck (NYSE: MRK). Genzyme and Alnylam expanded their collaboration on rare genetic diseases.

  • [By Jake L’Ecuyer]

    Equities Trading UP
    Shares of Alnylam Pharmaceuticals (NASDAQ: ALNY) got a boost, shooting up 53.25 percent to $101.47 after the company reported that it has acquired investigational RNAi Therapeutic assets from Merck (NYSE: MRK). Genzyme and Alnylam expanded their collaboration on rare genetic diseases.

  • [By Markus Aarnio]

    2. Alnylam Pharmaceuticals (ALNY), a biopharmaceutical company, engages in discovering, developing, and commercializing novel therapeutics based on RNA interference [RNAi].

5 Best Sliver Stocks To Buy Right Now: Piedmont Natural Gas Company Inc.(PNY)

Piedmont Natural Gas Company, Inc., an energy services company, engages in the distribution of natural gas to residential, commercial, industrial, and power generation customers in portions of North Carolina, South Carolina, and Tennessee. It also operates energy-related businesses, including unregulated retail natural gas marketing, regulated interstate natural gas storage, and intrastate natural gas transportation. The company serves approximately 1 million customers, including 51,800 customers served by municipalities. Piedmont Natural Gas Company, Inc. was founded in 1949 and is headquartered in Charlotte, North Carolina.


Advisors’ Opinion:

  • [By David Dittman]

    Question: What about Piedmont Natural Gas Co Inc (NYSE: PNY)?

    Answer: Piedmont Natural Gas posted great fiscal 2014 first-quarter numbers, including a 6.8 percent improvement in earnings per share and a 3.2 percent dividend increase. The dividend increase earned it a buy-under target increase to 35.

  • [By Marc Bastow]

    Natural gas and energy services provider Piedmont Natural Gas (PNY) raised its quarterly dividend 3.2% to 32 cents per share, payable April 15 to shareholders of record as of March 25. At more than a 3.75% yield, PNY is the highest yielder on this week’s list of dividend stocks.
    PNY Dividend Yield: 3.76%

5 Best Sliver Stocks To Buy Right Now: Diamond Offshore Drilling Inc. (DO)


Diamond Offshore Drilling, Inc. operates as an offshore oil and gas drilling contractor worldwide. It provides offshore drilling services in both the floater market, such as ultra-deepwater, deepwater, and mid-water; and in the non-floater and jack-up markets. The company operates a fleet of 44 offshore drilling rigs, consisting of 32 semisubmersibles, 7 jack-ups, and 5 dynamically positioned drillships, of which 4 are under construction. It serves independent oil and gas companies, and government-owned oil companies. The company was founded in 1989 and is headquartered in Houston, Texas. Diamond Offshore Drilling, Inc. is a subsidiary of Loews Corporation.


Advisors’ Opinion:

  • [By Ben Levisohn]

    The beatings that Seadrill (SDRL), Transocean (RIG), Diamond Offshore Drilling (DO), Atwood Oceanics (ATW) and Rowan (RDC) have taken this year has left them looking attractive to some value investors. Barclays, however, doesn’t think the stocks are as cheap as they look.

  • [By Ben Levisohn]

    The North Sea has been one of the few bright spots, if we can call it that, for offshore drillers this year, as dayrates have been dropping around the world as rigs come off contract. But Credit Suisse expects the region to get hit come 2015–and expose Rowan (RDC), Seadrill (SDRL), Transocean (RIG) and Diamond Offshore (DO) to more pain.

  • [By GuruFocus]

    Arnold van den Berg did bought heavily into good miners and oil producers heavily during the first quarter. These companies include Apache (APA), Diamond Offshore Drilling (DO), Randgold (GOLD), Yamada gold (AUY), Hecla Mining (HL) etc. You can see the complete list of his new buys here.

5 Best Sliver Stocks To Buy Right Now: HopFed Bancorp Inc.(HFBC)

HopFed Bancorp, Inc. operates as the holding company for Heritage Bank that provides various banking products and services primarily in western Kentucky, and middle and western Tennessee. The company offers a range of deposit products, including demand deposits, time deposits, money market accounts, passbook savings accounts, individual retirement accounts, and certificates of deposit. Its loan portfolio comprises one-to-four family residential loans, multifamily residential loans, construction loans, nonresidential loans, commercial real estate loans, and land and land development loans, as well as loans secured by deposits, other consumer loans, and commercial loans. The company, through its subsidiary, Fall and Fall Insurance Agency, sells life and casualty insurance products to individuals and businesses. HopFed Bancorp offers its products and services through its branch offices located in Hopkinsville, Murray, Cadiz, Elkton, Fulton, Calvert City, and Benton, Kentucky; and in Clarksville, Pleasant View, Ashland City, Kingston Springs, and Erin, Tennessee. The company was founded in 1879 and is headquartered in Hopkinsville, Kentucky.


Advisors’ Opinion:

  • [By Louis Navellier]

    HopFed Bancorp (HFBC), at $85 million in market cap, operates 18 branches in middle Tennessee and Western Kentucky and can be thought of as poster child for what is going on in the small banking sector. An activist investor took a stake in the bank and opposed an ill-advised acquisition. Instead, he suggested HopFed management get its own house in order. Management went along and canceled the deal, instituted a stock buyback plan and doubled the dividend. HFBC was upgraded to an “A” back in May and still is a “strong buy” right now.

5 Best Sliver Stocks To Buy Right Now: El Paso Pipeline Partners LP (EPB)


El Paso Pipeline Partners, L.P. engages in the ownership and operation of natural gas transportation pipelines and storage assets in the United States. The company holds a 100% interest in Wyoming Interstate Company, Ltd. (WIC), an interstate pipeline transportation company located in Wyoming, Utah, and Colorado. It operates approximately 800-mile WIC interstate natural gas pipeline system with a design capacity of approximately 3.5 billion cubic feet per day. The company also owns a 58% general partner interest in Colorado Interstate Gas Company, which operates an interstate natural gas pipeline system with approximately 4,300 miles of pipeline with a design capacity of approximately 4.6 billion cubic feet per day; and associated storage facilities with 37 billion cubic feet of underground working natural gas storage capacity. In addition, it owns a 60% general partner interest in Southern Natural Gas Company that operates an interstate natural gas pipeline system with ap proximately 7,600 miles of pipeline with a design capacity of approximately 3.7 billion cubic feet per day; and associated storage facilities with a total of approximately 60 billion cubic feet of underground working natural gas storage capacity. Further, the company owns interests in Elba Express Company, L.L.C., which operates an approximately 200-mile pipeline with a design capacity of 945 million cubic feet per day; and Southern LNG Company, L.L.C. that owns a liquefied natural gas receiving terminal with a storage capacity of 11.5 equivalent billion cubic feet. It serves natural gas distribution and industrial companies, electric generation companies, natural gas producers, other natural gas pipeline companies, and natural gas marketing and trading companies. El Paso Pipeline GP Company, L.L.C. serves as the general partner of the company. The company was founded in 2007 and is based in Houston, Texas. El Paso Pipeline Partners, L.P. is a subsidiary of El Paso Pipeline LP Holdings, L.L.C.


Advisors’ Opinion:

  • [By David Dittman]

    Question: El Paso Pipeline Partners LP (NYSE: EPB): Buy, hold or sell?

    Answer: I have El Paso Pipeline Partners rated a buy under 38. Management reaffirmed its $2.60 annualized distribution target, which implies no growth compared to 2013. But it will be maintained, and 2015 will be a better year.

  • [By Paul Ausick]

    Initial speculation about a coming disaster swirled around El Paso Pipeline Partners LP (NYSE: EPB). The company, now controlled by Kinder Morgan Inc. (NYSE: KMI), got a $3 million investment from CEO Richard Kinder and that ended the speculation about El Paso being the next to go.

  • [By Jon C. Ogg]

    What is surprising to 24/7 Wall St. is that the reaction was not worse elsewhere in the MLP sector. Most of the high-yield (distributions rather than dividends) MLPs held up well. One exception is El Paso Pipeline Partners, L.P. (NYSE: EPB) – in natural gas pipelines and terminaling – that was hit in sympathy with Boardwalk. Its units were down 2.6% to $30.74, and El Paso’s adjusted 52-week range is now $30.68 to $44.99 as they hit a new 52-week low on Monday. Its volume of almost 1.4 million units compared to an average volume of 861,000 units. El Paso’s market cap is $6.7 billion even after the drop and even at 52-week lows. Its distribution yield-equivalent screens out at 8.2%.

  • [By David Dittman]

    Question: If an investor has a long term outlook, would you consider El Paso Pipeline Partners LP (NYSE: EPB) at current prices to be a good value or does the risk of trying to catch a falling knife outweigh the benefits? At what price would you consider it to be an excellent value play given its projected flat distribution through 2016? How likely is a distribution cut prior to re-establishing distribution growth in 2017?